Shenzhen Bioeasy Biotechnology Co.,Ltd. Posted 69.7 Million Yuan Net Loss in First Half of 2023

Shenzhen Bioeasy Biotechnology Co.,Ltd. (深圳市易瑞生物技术股份有限公司) (300942.SZ) reported a net loss of 69.7 million yuan in the first half of 2023, reversing a net profit of 151.4 million yuan for the same period in the previous year.

Meanwhile, the company posted 112.1 million yuan in revenue, down 76.4% year-on-year.

At the end of the reporting period, it had 1.2 billion yuan in total assets and 286.2 million yuan in total liabilities, with a liability-to-asset ratio of 24.2%.